Combined-modality therapy in locally advanced primary rectal cancer

Carlo Ratto, Vincenzo Valentini, Alessio Giuseppe Morganti, Brunella Barbaro, Claudio Coco, Luigi Sofo, Mario Balducci, Pier C. Gentile, Fabio Pacelli, Giovanni B. Doglietto, Aurelio Picciocchi, Numa Cellini

Risultato della ricerca: Contributo in rivistaArticolo in rivista


PURPOSE: Patients with unresectable, locally advanced rectal cancer are reported to have a dismal prognosis. The aim of this study was to analyze the effect of combined-modality therapy on clinical outcome. METHODS: From March 1990 to December 1997, 43 patients (28 males; median age, 62 years; median follow-up, 74 months) with locally advanced (T4 and/or N3) nonmetastatic rectal cancer received external-beam radiation (23.6 plus 23.6 Gy (split course), 8 patients; 45 Gy, 35 patients) plus 5-fluorouracil (96-hour continuous infusion, Days 1-4, at 1,000 mg/m2/day) and mitomycin C (10 mg/m2, intravenous bolus, Day 1). Concomitant chemotherapy was repeated at the beginning of the second course (split-course group) or in the last week of radiotherapy (continuous-course group). After 6 to 8 weeks, patients were evaluated for surgical resection and intraoperative radiation therapy (10 to 15 Gy). Thereafter, adjuvant chemotherapy (5-fluorouracil plus leucovorin, 6-9 courses) was prescribed. RESULTS: During chemoradiation, 5 patients (11.6 percent) developed Grade 3 to 4 hematologic toxicity. After chemoradiation, 29 patients (67.4 percent) had an objective clinical response (complete response, 2.3 percent; partial response, 65.1 percent). Thirty-eight patients underwent radical surgery (anterior resection, 24 patients; abdominoperineal resection, 14 patients; intraoperative radiation therapy boost on the tumor bed, 19 patients), and 2 patients had partial tumor resection. No perioperative deaths occurred in the patient group. Five-year survival and local control rates were 59.9 and 69.1 percent, respectively. Distant metastasis occurred in 44.2 percent of patients. Statistically significant relationships between intraoperative radiation therapy and local control (P = 0.0104), radical surgery and survival (P = 0.0120), and adjuvant chemotherapy and disease-free survival (P = 0.0112) were observed. CONCLUSIONS: Our data suggest that combined-modality therapy was relatively well tolerated and resulted in good local control and survival. With regard to the impact of surgical resection on survival, additional studies aimed at improving the local response rate are necessary, whereas the positive impact of intraoperative radiotherapy on local control appears to justify the inclusion of this therapeutic modality in prospective multi-institutional trials.
Lingua originaleEnglish
pagine (da-a)59-67
Numero di pagine9
Stato di pubblicazionePubblicato - 2003


  • 5-Fluorouracil
  • Combined therapies
  • Continuous infusion
  • Prognostic factors
  • Intraoperative radiotherapy
  • Locally advanced rectal cancers
  • Mitomycin C
  • External radiation therapy


Entra nei temi di ricerca di 'Combined-modality therapy in locally advanced primary rectal cancer'. Insieme formano una fingerprint unica.

Cita questo